# Design Therapeutics, Inc.: Form 8-K, filed Mar 9, 2026

- Company: [Design Therapeutics, Inc.](/companies/dsgn.md) (CIK 1807120)
- Form: 8-K
- Filed: 2026-03-09
- Accepted by EDGAR: Mar 9, 2026, 16:06 ET
- Period: 2026-03-09
- Accession: 0001193125-26-098474
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1807120/000119312526098474/dsgn-20260309.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1807120/000119312526098474/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1807120/000119312526098474/dsgn-20260309.htm

Filed Mar 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-098474. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
